Delivery Order 36C24626D0001-36C24626N0119
- Not listed
- Cepheid has been awarded a delivery order valued at $341,103.30 for Cepheid Molecular Diagnostic Testing System Reagents and Assays under the Veterans Integrated Service Network (VISN) 6 Indefinite Delivery, Indefinite Quantity (IDIQ) contract. This firm fixed-price delivery order was awarded on October 14, 2025, with an ultimate completion date of March 31, 2026. The contract carries no set-aside designation and is funded by the Department of Veterans Affairs through VISN 6. Cepheid, a...
- Cepheid has been awarded a delivery order valued at approximately $310K for molecular diagnostic testing system reagents and assays supporting Veterans Integrated Service Network 6 (VISN 6), a component of the Department of Veterans Affairs' healthcare system. This firm fixed-price delivery order, with no set-aside designation, will be performed through March 31, 2026, and represents a continuation of Cepheid's ongoing supply of diagnostic solutions to the VA's regional health networks. The...
- Cepheid has been awarded a firm fixed-price delivery order valued at $40,704.72 by the Department of Veterans Affairs' Veterans Integrated Service Network 9 (VISN 9). The contract, with an ultimate completion date of May 31, 2025, is for molecular diagnostic solutions to be delivered and performed in Sunnyvale, California. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of advanced diagnostic systems and testing solutions to the...
- This delivery order, awarded on October 1, 2025, to Cepheid Inc. for $299,404 provides molecular diagnostic testing system reagents and assays to Veterans Integrated Service Network (VISN) 6 through March 31, 2026. The contract utilizes a firm fixed-price structure with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, will supply products and services supporting infectious disease detection and clinical testing across VISN 6's...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a purchase order valued at $5.17 million by the Department of Veterans Affairs' Veterans Integrated Service Network 8 on October 1, 2022. This firm fixed-price contract, with no set-aside designation, is a modification to an existing agreement that adjusts clinical quantities based on updated workload estimates for microbiology testing services. The contract calls for an all-inclusive...
- The Department of Veterans Affairs' Veterans Integrated Service Network 6 awarded a $198,080.05 delivery order to Cepheid for molecular diagnostic testing system reagents, assays, and equipment lease services. This firm fixed-price contract, with an ultimate completion date of September 30, 2025, represents a non-set-aside procurement supporting the VA's clinical laboratory and diagnostic capabilities. Cepheid, a Sunnyvale-based manufacturer of advanced molecular diagnostic solutions, will...
- Cepheid was awarded a delivery order valued at $172,259.87 for Cepheid reagents by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 on October 1, 2024. This firm fixed-price contract, with an ultimate completion date of September 30, 2025, carries no set-aside designation. The work will be performed in Sunnyvale, California. Cepheid is a leading manufacturer of molecular diagnostic solutions specializing in advanced diagnostic systems and test kits for infectious...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 6 awarded a delivery order to Cepheid Inc. for Cepheid Molecular Diagnostic Testing System Reagents and Assays valued at $537,017.20, effective October 1, 2025, with an ultimate completion date of March 31, 2026. This firm fixed-price delivery order was awarded without set-aside designation and represents a task order issued under Cepheid's larger IDV vehicle with VISN 6, which holds a total ceiling value of $32.8...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $1,854.00 by the Medical Supply Chain (a Defense agency) on May 21, 2025, with an ultimate completion date of May 29, 2025. The contract, issued without set-aside designation under contract number GXGBSLBXC-10, is to be performed in Sunnyvale, California. This delivery order represents a discrete procurement action under one of Cepheid's existing...
- This delivery order, awarded on October 1, 2025, represents a $465,517 firm fixed-price contract between the Department of Veterans Affairs Veterans Integrated Service Network 6 (VISN 6) and Cepheid Inc. for molecular diagnostic testing system reagents and assays. The contract extends through March 31, 2026, and is issued under VISN 6's larger Indefinite Delivery Indefinite Quantity (IDIQ) vehicle valued at $32.8 million through September 30, 2030. This delivery order carries no set-aside...
- 36C24626D0001Indefinite Delivery Contract
- 36C24626D0001-36C24626N0119Delivery Order
Cepheid Inc., a leading manufacturer of molecular diagnostic systems based in Sunnyvale, California, was awarded a delivery order valued at $970,216.62 on October 1, 2025, for Cepheid Molecular Diagnostic Testing System reagents and assays supporting Veterans Integrated Service Network 6 (VISN 6). This firm fixed-price delivery order, which extends through March 31, 2026, carries no set-aside designation and will be performed in Sunnyvale, California. The award funds the supply of molecular diagnostic reagents and assays utilized across the VA's VISN 6 healthcare system, enabling detection and diagnosis of infectious diseases and clinical conditions through Cepheid's GeneXpert diagnostic platform. This delivery order is issued under Cepheid's larger Indefinite Delivery Vehicle (IDV) contract with VISN 6, a single-award vehicle valued at $32.8 million and effective through September 30, 2030. The IDV provides the VA system with continuous access to molecular diagnostic testing solutions, supporting the Department of Veterans Affairs' clinical laboratory operations and patient care capabilities. Cepheid's molecular diagnostic portfolio, which includes testing for COVID-19, influenza, respiratory syncytial virus, and other infectious diseases, serves as critical infrastructure for the VA's healthcare delivery mission across multiple Veterans Integrated Service Networks.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6550--Cepheid Molecular Diagnostic Testing System Reagents and Assays - VISN 6 BPA | 36C24625R0009 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 | Special Notice 1/2 | 11/13/24, 3:54 PM | |
6550--Cepheid Molecular Diagnostic Testing System Reagents and Assays - VISN 6 BPA | 36C24626D0001-1 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 | Award Notice 2/2 | 10/2/25, 12:26 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $970.2k | 10/1/25 |